Top API Manufacturer Expands Innovation and Global Supply Capabilities in Pharmaceutical Development
Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...
TOKYO, October 22, 2015 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today the decision to construct a new plant for manufacturing antibody active pharmaceutical ingredients (API) ...
More than $21 billion of Lilly’s domestic manufacturing commitments this decade have been directed to Indiana.¹ The Lebanon ...
−CDMO with a Six Decades-Long Reputation for Quality and Service Doubles Its Capacity to Take on New Development Projects− MORTON GROVE, Ill.--(BUSINESS WIRE)--Regis Technologies, Inc. today announced ...
Dublin, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The "Europe Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report by Synthesis, by Manufacturer, by Type (Generic APIs, Innovative ...
In the current industry landscape, API quality can make or break a drug product. LGM Pharma stands out by treating supplier relationships as strategic partnerships rather than transactions. In this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results